Innovative experimental models in oncology to select effective drug candidates

IMODI is a French consortium to develop new experimental models of cancer. The project organizes a health industrial sector to meet the needs of the scientific community, whether private or public, in research and development of more efficient test systems to improve the selection of more effective diagnostic and therapeutic agents.

IMODI is a consortium of 18 partners. It focuses its activities on 4 major R&D axes:

  • Developing animal models and cell-based assays
  • Humanizing the tumor microenvironment in mice
  • Demonstrating the predictivity of experimental models, based on data-mining tools
  • Studying the microbiota in cancer patients

Pathologies of interest are colorectal cancer, prostate cancer, lung cancer, breast cancer, ovary cancer, liver cancer, pancreas cancer, lymphoma, myeloma, leukemia.

Have a look today to our PDX database online!

Follow IMODI's lastest news:  Linkedin twitter